A detailed history of Gouws Capital LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Gouws Capital LLC holds 20,676 shares of ZTS stock, worth $3.66 Million. This represents 2.73% of its overall portfolio holdings.

Number of Shares
20,676
Previous 21,406 3.41%
Holding current value
$3.66 Million
Previous $3.71 Million 8.87%
% of portfolio
2.73%
Previous 2.66%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 06, 2024

SELL
$172.58 - $196.48 $125,983 - $143,430
-730 Reduced 3.41%
20,676 $4.04 Million
Q2 2024

Jul 31, 2024

SELL
$145.54 - $178.83 $17,464 - $21,459
-120 Reduced 0.56%
21,406 $3.71 Million
Q1 2024

May 08, 2024

SELL
$165.67 - $199.94 $197,147 - $237,928
-1,190 Reduced 5.24%
21,526 $3.64 Million
Q4 2023

Jan 24, 2024

BUY
$151.44 - $200.09 $121,152 - $160,072
800 Added 3.65%
22,716 $4.48 Million
Q3 2023

Nov 13, 2023

BUY
$167.14 - $192.77 $68,527 - $79,035
410 Added 1.91%
21,916 $3.81 Million
Q2 2023

Aug 03, 2023

BUY
$160.94 - $186.23 $62,766 - $72,629
390 Added 1.85%
21,506 $3.7 Million
Q1 2023

May 09, 2023

BUY
$145.48 - $175.02 $101,981 - $122,689
701 Added 3.43%
21,116 $3.51 Million
Q4 2022

Feb 08, 2023

SELL
$131.14 - $157.47 $231,724 - $278,249
-1,767 Reduced 7.97%
20,415 $2.99 Million
Q3 2022

Oct 28, 2022

SELL
$148.29 - $182.55 $14,532 - $17,889
-98 Reduced 0.44%
22,182 $3.29 Million
Q2 2022

Jul 28, 2022

BUY
$155.97 - $200.09 $81,104 - $104,046
520 Added 2.39%
22,280 $3.83 Million
Q1 2022

Apr 26, 2022

BUY
$181.39 - $234.03 $98,857 - $127,546
545 Added 2.57%
21,760 $4.1 Million
Q4 2021

Feb 03, 2022

BUY
$193.69 - $247.03 $4.11 Million - $5.24 Million
21,215 New
21,215 $5.18 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.8B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Gouws Capital LLC Portfolio

Follow Gouws Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gouws Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gouws Capital LLC with notifications on news.